Reductions seen in office systolic blood pressure for those in no-CKD, stage 3a CKD, and stage 3b CKD groups. (HealthDay News) — Radiofrequency renal denervation (RDN) yields a clinically meaningful ...
Chronic kidney disease (CKD) has long remained at the margins of the evidence base for the cardiovascular benefits of blood-pressure lowering. The absolute risk of cardiovascular events in people with ...
A high-risk cohort of beneficiaries with chronic kidney disease (CKD) stage 3 have a profile similar to patients with CKD stages 4 and 5, indicating potential benefit of earlier nephrology ...
In a primary care cohort, the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation vs the Modification of Diet in Renal Disease (MDRD) equation classified 7.73% vs 6.57% of individuals ...
RADNOR, Pa., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results